<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="142823">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01777984</url>
  </required_header>
  <id_info>
    <org_study_id>EK-08-122-0708</org_study_id>
    <nct_id>NCT01777984</nct_id>
  </id_info>
  <brief_title>Impact of Visceral Fat on the Pathogenesis of Age-related Macular Degeneration</brief_title>
  <official_title>Impact of Visceral Fat on the Pathogenesis of Age-related Macular Degeneration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rudolf Foundation Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rudolf Foundation Clinic</source>
  <oversight_info>
    <authority>Austria: Ethikkommission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the relationship among the body fat distribution,
      especially the visceral fat, in patients with age-related macular degeneration in comparison
      to patients with a normal fundus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study the investigators want to examine the relationship among visceral fat, serum
      leptin levels, and high-sensitive CRP (hsCRP), Tnf-alpha, Amyloid alpha and Amyloid Beta
      serum levels in patients with age-related macular degeneration in comparison to patients
      with a normal fundus.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>December 2009</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">May 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>visceral fat ratio</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Leptin, Amyloid, TNF alpha, CRP</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Age-related Macular Degeneration</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients with age-related macular degeneration, over 60
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  man and women over 18 years old

          -  filled informed consent

          -  diagnosis of age-related macular degeneration

        Exclusion Criteria:

          -  inherited retinal disease

          -  other acquired retinal macular disease

          -  missing informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susanne Binder</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rudolf Foundation Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rudolf Foundation Clinic</name>
      <address>
        <city>Vienna</city>
        <zip>1030</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 24, 2013</lastchanged_date>
  <firstreceived_date>December 1, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Macular Degeneration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
